Company Filing History:
8 out of 973 
3 out of 15,484 
2 out of 261 
Years Active: 2001-2021
Title: Eugene W Gerner: Innovator in Cancer Research
Introduction
Eugene W Gerner is a distinguished inventor based in Tucson, AZ, recognized for his significant contributions to the field of medical research and innovation. With a remarkable portfolio of 12 patents, his work primarily focuses on therapeutic methods related to familial adenomatous polyposis (FAP) and cancer treatment.
Latest Patents
Among Gerner's latest patents are two notable innovations. The first, titled "Methods for treating familial adenomatous polyposis," unveils methods for preventing or delaying the need for surgical intervention in patients with FAP who have an intact lower gastrointestinal tract. This invention incorporates pharmaceutical therapies that consist of eflornithine and sulindac, aiming to prevent or delay neoplasia and cancer formation in affected patients.
The second patent, "Predictive markers for polyamine inhibitor cancer therapies," relates to therapeutic methods and medical uses that identify cancer marker surrogates for increased polyamine expression. These markers are invaluable for identifying patients suitable for treatment with polyamine synthesis inhibitors and for monitoring therapeutic responses when such agents are utilized.
Career Highlights
Eugene W Gerner has made a significant impact through his work at leading research institutions. He has collaborated with notable entities such as the University of Arizona and the University of California, contributing to various projects that advance cancer research and treatment methodologies. His career accomplishments underscore his commitment to improving patient outcomes through innovative medical solutions.
Collaborations
Throughout his career, Gerner has collaborated with esteemed professionals in his field, including Frank L Meyskens and David T Harris. These partnerships underscore the collaborative nature of research and innovation, as they work together to tackle pressing health issues related to cancer and other diseases.
Conclusion
Eugene W Gerner's innovative inventions and dedication to cancer research have established him as a leading figure in the medical community. His patented methods are set to enhance treatment options for patients with familial adenomatous polyposis and contribute to advancements in cancer therapies, ultimately aiming to improve the quality of life for many individuals.